Synvect has raised a $3 million Seed Round from prominent investors, including the Bill & Melinda Gates Foundation, Antler, NuFund, and Redbud. The funding will accelerate the development and deployment of Synvect's CRISPR-based technology, offering a scalable, eco-friendly solution to suppress disease-carrying mosquito populations.

Synvect is a biotechnology startup committed to eliminating vector-borne diseases through scalable, precision-driven mosquito suppression technology. Founded by scientists from UC San Diego, Synvect leverages CRISPR innovations to provide a safe, effective alternative to chemical pesticides.